FIELD: medicine, obstetrics. SUBSTANCE: the method puts forward to apply perfluorane to be intravenously injected through infusomatic device at 50 ml/h velocity at the dosage of 3.5 ml/kg body weight, 3-4 times, not more. The method in question enables to improve uterine- placental blood flow, increase saturation of intervillous space with an oxygen to enhance activity of extravillous cytotrophoblast. Selected doses and modes enable to exclude side effects caused by perfluorane in pregnant women. EFFECT: higher efficiency of therapy. 2 ex, 10 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF CHRONIC PLACENTAL INSUFFICIENCY | 2007 |
|
RU2348399C2 |
| METHOD FOR PREDICTING PLACENTAL DEFICIENCY | 2000 |
|
RU2187805C2 |
| METHOD FOR TREATING A SUBCOMPENSATED FORM OF PLACENTAL DEFICIENCY | 2000 |
|
RU2192234C2 |
| METHOD OF DIAGNOSING FETUS GROWTH DELAY | 2000 |
|
RU2172958C1 |
| METHOD OF PREVENTING SEVERE FORMS OF OBSTETRICAL PATHOLOGY | 2010 |
|
RU2422149C1 |
| METHOD FOR CARRYING OUT ULTRASONIC EXAMINATION OF LARGE INTESTINE WALL | 2001 |
|
RU2204329C2 |
| METHOD FOR PREVENTING PATHOLOGICAL PREGNANCY SYNDROME | 2015 |
|
RU2575789C1 |
| MEDICATION AND METHOD FOR PREVENTION OF HEMOREOLOGICAL DISORDERS IN PREGNANT WOMEN WITH OBLITERATED FORMS OF HYPERANDROGENIA AND FETOPLACENTAL INSUFFUCIENCY | 2007 |
|
RU2355396C2 |
| METHOD OF PREVENTION OR TREATMENT OF INTRAUTERINE GROWTH RETARDATION SYNDROME | 2011 |
|
RU2473339C1 |
| METHOD FOR PREVENTING CHRONIC HYPOXIA AND FOETAL DEVELOPMENT RETARDATION | 2018 |
|
RU2699559C2 |
